Physician profile
Monisha Banerjee
NPI 1518370097
$1,360.02
in general payments reported to CMS, 2019-2025
13 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $27.35 · 2024: $1,333.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,054 · Travel and Lodging: $297 · Gift: $8.74.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,053.93 |
| Travel and Lodging | $297.35 |
| Gift | $8.74 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $831.33 | 2024 | |
| Rti Surgical, INC | $121.42 | 2024 | |
| Conmed Corporation | $96.37 | 2024 | Airseal |
| Virtual Incision Corporation | $85.00 | 2024 | Mira |
| Tempus Ai, INC | $38.35 | 2024 | |
| Activ Surgical, INC. | $34.05 | 2024 | Activsight |
| Medtronic, INC. | $33.34 | 2024 | Interstim |
| Aroa Biosurgery Incorporated | $26.06 | 2024 | |
| Axonics, INC. | $24.89 | 2024 | Axonics, Bulkamid |
| Baxter Healthcare | $22.53 | 2024 | Perclot |
| Takeda Pharmaceuticals U.S.A., INC. | $19.94 | 2023 | Gattex |
| Innovation Technologies INC | $19.33 | 2024 | Irrisept |
| Kerecis Limited | $7.41 | 2023 | Kerecis Omega3 Surgiclose, Kerecis Omega3 Marigen, Kerecis Omega3 Graftguide |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Monisha Banerjee listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.